(Q39675475)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20661229%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

title

HGF/c-Met pathway has a prominent role in mediating antiapoptotic signals through AKT in epithelial ovarian carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20661229%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20661229%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

Rong Bu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20661229%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Prashant Bavi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20661229%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Azhar R Hussain

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20661229%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Fouad Al-Dayel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20661229%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Samir Ghourab

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20661229%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Maqbool Ahmed

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20661229%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Khawla S Al-Kuraya

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20661229%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

publication date

26 July 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20661229%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

published in

Laboratory Investigation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20661229%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

91

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20661229%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20661229%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

124-137

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20661229%20AND%20SRC:MED&resulttype=core&format=json

Caspases: potential targets for regulating cell death.

8 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.136

X-linked IAP is a direct inhibitor of cell-death proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.136

XIAP: apoptotic brake and promising therapeutic target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.136

Preclinical characterization of AEG35156/GEM 640, a second-generation antisense oligonucleotide targeting X-linked inhibitor of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.136

Application of XIAP antisense to cancer and other proliferative disorders: development of AEG35156/ GEM640

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.136

Downregulation of XIAP expression in ovarian cancer cells induces cell death in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.136

c-Met: structure, functions and potential for therapeutic inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.136

Effect of a c-Met-specific, ATP-competitive small-molecule inhibitor SU11274 on human ovarian carcinoma cell growth, motility, and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.136

RNA interference reveals that ligand-independent met activity is required for tumor cell signaling and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.136

Inhibition of phosphatidylinositol 3'-kinase/AKT signaling promotes apoptosis of primary effusion lymphoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.136

X-Linked inhibitor of apoptosis protein expression level in colorectal cancer is regulated by hepatocyte growth factor/C-met pathway via Akt signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.136

Reduced or absent cyclin H expression is an independent prognostic marker for poor outcome in diffuse large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.136

Leptin receptor expression in Middle Eastern colorectal cancer and its potential clinical implication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.136

Tissue microarray-based studies of patients with lymph node negative breast carcinoma show that met expression is associated with worse outcome but is not correlated with epidermal growth factor family receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.136

C-Met overexpression in node-positive breast cancer identifies patients with poor clinical outcome independent of Her2/neu

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.136

Overexpression of leptin receptor predicts an unfavorable outcome in Middle Eastern ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.136

Cyclooxygenase-2 inhibition inhibits PI3K/AKT kinase activity in epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.136

Curcumin induces apoptosis via inhibition of PI3'-kinase/AKT pathway in acute T cell leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.136

Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.136

Role of phosphatidylinositol 3'-kinase/AKT pathway in diffuse large B-cell lymphoma survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.136

Differentiation stage-specific activation of p38 mitogen-activated protein kinase isoforms in primary human erythroid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.136

Sanguinarine-dependent induction of apoptosis in primary effusion lymphoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.136

Curcumin suppresses growth and induces apoptosis in primary effusion lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.136

Ubiquitin-proteasome system stress sensitizes ovarian cancer to proteasome inhibitor-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.136

c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.136

Functional analysis of HGF/MET signaling and aberrant HGF-activator expression in diffuse large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.136

Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.136

Met receptor tyrosine kinase: enhanced signaling through adapter proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.136

Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.136

XIAP and survivin as therapeutic targets for radiation sensitization in preclinical models of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.136

Overexpression of the Met/HGF receptor in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.136

p38 MAPK turns hepatocyte growth factor to a death signal that commits ovarian cancer cells to chemotherapy-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.136

Hepatocyte growth factor sensitizes human ovarian carcinoma cell lines to paclitaxel and cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.136

Hepatocyte growth factor/scatter factor inhibits UVB-induced apoptosis of human keratinocytes but not of keratinocyte-derived cell lines via the phosphatidylinositol 3-kinase/AKT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.136

Scatter factor protects epithelial and carcinoma cells against apoptosis induced by DNA-damaging agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.136

Hepatocyte growth factor exerts a proliferative effect on oval cells through the PI3K/AKT signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.136

Anti-apoptotic role of focal adhesion kinase (FAK). Induction of inhibitor-of-apoptosis proteins and apoptosis suppression by the overexpression of FAK in a human leukemic cell line, HL-60.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.136

Akt phosphorylation and stabilization of X-linked inhibitor of apoptosis protein (XIAP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.136

Genes regulated by hepatocyte growth factor as targets to sensitize ovarian cancer cells to cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.136

The inhibitors of apoptosis (IAPs) and their emerging role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.136

7 January 2021

Cisplatin Resistance in an Ovarian Carcinoma Is Associated With a Defect in Programmed Cell Death Control Through XIAP Regulation

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.136

7 January 2021

Resistance of ovarian carcinoma cells to docetaxel is XIAP dependent and reversible by phenoxodiol.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.136

7 January 2021

c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.136

7 January 2021

The cytokine hepatocyte growth factor/scatter factor inhibits apoptosis and enhances DNA repair by a common mechanism involving signaling through phosphatidyl inositol 3' kinase

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.136

7 January 2021